The next immediate step is for HWGB Biotech Sdn Bhd (“HWGB Biotech”) (fka HWG Consortium Sdn Bhd) to submit the Test Kit to the Medical Device Authority (“MDA”) for approval. Once the approval from MDA is obtained, then HWGB Biotech can import and market the Test Kit in Malaysia.
This counter is gonna fly!!! Lots of great news: 1) Repurpose polio vaccine for Covid. This is very different from the other vaccine R&D. If the repurpose vaccine shows results this is much easier to get approval and market since it is already an existing vaccine 2) Approval by Indonesian authorities for manufacturing and sales of pharmaceutical products in their Batam plant 3) New test kit with 100% accuracy
@GoUpUp - FYI Repurpose polio vaccine for Covid is just a stopgap measure until such time the actual Covid Vaccine has been approved. Once the actual Covid Vaccine has been approved, the repurposed polio vaccine will cease to be useful and may be rendered obsolete as it does not have any advantages or added value over the actual Covid Vaccine.
@NPRA1985 Yes am aware of that. But we do need to realistically understand that the actual Covid vaccine will not be so quick to be released for public use. There are a lot of data and certification required to get a new vaccine out no matter what China is saying.
Anyone know how this vaccine is going to be like or is there any information? How will it be distributed and who will have final say in the distribution? In vaccine investment - it is a 50-50 thing. This counter is better than Bintai in the sense that it has inked many JVs with companies in the study and making of vaccines. But there is a ceiling price for all stocks for all it's worth. Continuously chasing its high will end up being caught by smartmoney who has better and faster data than the common people in the streets like you and me who depend on rumours. Those who do more research will benefit and they may share with you their findings - AFTER they already bought into the market. So, watch this stock at its current high price. If you have profited, good. If not, a wait may not be a bad thing. Until someone finds an effective vaccine, any rumour is only as good as coffeeshop talk
And even then... the producers will not be able to ramp up manufacturing so quickly in the beginning. So having a repurpose vaccine as a short term stop-gap will have its value.
Don't get me wrong. I too hope that the actual vaccine can be release as soon as possible to help alleviate the pandemic globally and hopefully return us all to life as we know it.
Yes, but take this statement as a caution. We are investing, not throwing salt into sea.
"We are following closely on the developments in this CRUCIAL venture of our healthcare business as we want to do our bit in helping to combat the virus that has affected the health of so many, including their livelihoods and income,” Dato’ Aaron Lim said."
Meaning if it doesn't get through, HWGB is in deep sea. Just follow developments closely. There are currently 162 possible candidates in different stages of trials. Only the Chinese claim that theirs are at the final stages and already on thousands of human trials.US based ones are more stringent . Eli Lilly just halted testing because of one unexplained health issue of one of its respondents. As a result, EL shares were dropped cold.
Malaysia just joined Covac. Looks like when vaccine is ready, only one of two Government appointed firms will benefit. Unless those purported vaccine manufacturers that have joined venture with our local companies can really produce a viable vaccine. If not, a lot of investors will be caught. So, if you are investing in vaccine counters per see, please keep a sharp eye on all the details if you have a lot running. If not, slow sell may see a huge wipe-out of what you put in.
Now this turns the tide. While Bintai Kinden has practically nothing to show, HWGB has already one in the bag. Its venture with Wuhan Easydiagnosis Biomedicine Co Ltd with the test kits which has met MOH approvals means it can distribute it here - and overseas in neighbouring countries using that testimonial as backing. If its venture bears fruit, we are looking at a runaway locomotive. Prior, we are still talking about heresay. This is news. Buy on news, they say?
HWGB's partner is listed on the Shenzhen Stock Exchange under CNI Biomedicine I think. Look up its stock and see that it has grown over 24% since last five months and still climbing. Congrats all who are on this wagon.
If HWGB breaks 79sen next week, it will be comfortable in its retracement upwards - which means at its high of 1.36 on August 25. The rise in potential will depend on how fast its other vaccine venture is coming along. From what is know, the company is quite active in making alliances at strategic places, so you can rest assured that at least the company is responding to what investors are looking for or interested in. If you study Bintai, this stock is at least pursuing aggressively its end product. So that you roughly know what you are buying into
Wuhan lab is the pioneer in combating covid outbreak. The frontliners and medics have high exposure & experienced in dealing with the outbreak in early November
I think China will see its wish of producing vaccine for the good of humanity come true. This will be its present to the US that has been continually critical of it for the virus. If China vaccine proves without side effects and can alleviate some of the Covid 19 symptoms, then it could bring enough goodwill that may translate into other trade benefits
haha, i saw big shark queue to sell at RM0.90 just now, don't want to wait until big shark sell then only I sell. This is strategic of investment, haha.
Ho Wah Genting Bhd’s wholly owned subsidiary, HWGB Biotech Sdn Bhd’s joint venture partner, E-Mo Biology Inc (EBI) is collaborating with a US-based lab facility to develop and produce companion diagnostic systems.
If you google E-Mo Biology Inc (EBI), you wouldn't found any results... anybody noticed that?
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 411 views | 10 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DezMyWay
16 posts
Posted by DezMyWay > 2020-10-14 11:28 | Report Abuse
The next immediate step is for HWGB Biotech Sdn Bhd (“HWGB Biotech”) (fka HWG Consortium Sdn Bhd) to submit the Test Kit to the Medical Device Authority (“MDA”) for approval. Once the approval from MDA is obtained, then HWGB Biotech can import and market the Test Kit in Malaysia.
Go Go Go...!!!